Amphastar Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Amphastar Pharmaceuticals, Inc. (AMPH) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 1.01 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-02-26
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1.01M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 825.42K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 920.38K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1.01M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number |
|---|---|
| 2025-12-31 | 1.01M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 825.42K shares 10-K · filed 2026-02-26 |
| 2023-12-31 | 920.38K shares 10-K · filed 2025-03-03 |
| 2022-12-31 | 1.01M shares 10-K · filed 2024-02-29 |
| 2021-12-31 | 1.18M shares 10-K · filed 2023-03-01 |
| 2020-12-31 | 1.16M shares 10-K · filed 2022-03-11 |
| 2019-12-31 | 1.10M shares 10-K · filed 2021-03-15 |
| 2018-12-31 | 1.21M shares 10-K · filed 2020-03-16 |
| 2017-12-31 | 1.39M shares 10-K · filed 2019-03-15 |
| 2016-12-31 | 1.22M shares 10-K · filed 2018-03-14 |
| 2015-12-31 | 866.54K shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |